As mentioned above miR-100 has been shown to be down-regulated in clear cell ovarian carcinoma cell lines and its over-expression in them inhibited mTOR signaling and enhanced sensitivity to rapamycin analog RAD001 (everolimus) [83] (Table-2). This evidence concerns the gene MTOR and ovarian clear cell cancer.